Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

Recruiting now · Not applicable

Conditions studied: Irritable Bowel Syndrome

In brief

To explore the efficacy of a single low dose of esketamine for patients with irritable bowel syndrome (IBS).

Key facts

Study ID
NCT06788444
Run by
Beijing Tiantan Hospital
People needed
552
Starts
2025-09-18
Expected to finish
2027-12-31
Last updated by the study team
2025-09-10

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.